FDA Investigator K Gonzlez
K Gonzlez has conducted inspections on 29 sites in 8 countries as of 09 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
29
Last Inspection Date:
09 Nov 2023
Investigator Role:
MDSAP Auditor
Redica ID:
Countries of Inspections:
Germany,
United States of America,
Korea (Republic of),
Ireland,
Canada,
Switzerland,
Costa Rica,
Puerto Rico
FDA Investigators that have inspected at least one site in common with K Gonzlez:
Aaron L Dunbar,
Althea A Williams,
Amy M Codella,
Amy M Cramer,
Angela E Glenn,
Annette Melendez,
Anthony R Petriella,
Ashley A Mutawakkil,
Benjamin J Dastoli,
Bleta Vuniqi,
Bonnie E Conley,
Bonnie E Pierson,
Byungja E Marciante,
Calvin K Cook,
Catherine J Laufmann,
CDR Sean T Creighton,
Charles J Chacko,
Charles M Spyr,
Cynthia L Gorveatt,
Danny D Horner,
Dawn M Mccabe,
Dennis G Kawabata,
Dianiris C Ayala,
Dolores Harper,
Dorothy J Denes,
Edward O'shaughnessy,
Elizabeth B Griffin,
Eric S Pittman,
Frank Verni,
Gary Durbiel Goldner,
George G Calafactor,
George T Allen, Jr,
Gonzlezk Gonzalez,
Herminio C Francisco,
Iris C Macinnes,
James A Lane,
James D Planchon,
James E Frye,
James M Odonnell,
Janete F Guardia,
Jocelyn E Massey,
John A Hall,
John A Sciacchitano,
Joshua J Silvestri,
Karen A Coleman,
Karen M Rodriguez,
Kimberly Lewandowski Walker,
Kimberly M Lichter,
Kinh Q Mac,
Laiza V Garcia,
Lanita F Kelley,
Lisa M Lopez,
Lori J Silverstein,
Maida Henesian (NMI),
Marc R Dickens,
Marcelo O Mangalindan, Jr,
Marilyn Santiago,
Martha Sullivan Myrick,
Miaja Umaedi,
Michael A Taylor,
Michael D Omeara,
Michael J Nerz,
Michael Serrano,
Miguel Gmanzano Maldonado,
Monica J Wilkins,
Msdap Gonzlezk,
Philip E Ake,
Raffi B Papazian,
Robert G Ruff,
Ryan J Benedict,
Sarah Forney,
Sargum C Sood,
Selene T Torres,
Sharon I Gundersen,
Sonia M Monges,
Sonya L Karsik, RAC,
Stephanie T Durso,
Stephen D Eich,
Stephen R Souza,
Steven E Kane,
Steven R Ziser,
Tania E Vizcaino,
Trudy R Papson,
Ve Garcia,
Vivian Garcia,
Wanda J Torres,
William D Tingley,
Xiaojun Yan
K Gonzlez's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2016 | EIR | Karl Storz SE & Co. KG - EIR, 2016-03-03 |
March, 2016 | FDA 483 | KARL STORZ GMBH & CO. KG - Form 483, 2016-03-04 |
March, 2016 | EIR | STORZ ENDOSKOP PRODUKTIONS GMBH - EIR, 2016-03-09 |
March, 2016 | EIR | Karl Storz Gmbh & Co. Kg - EIR, 2016-03-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more